"MOMENTUM" DCA PROTOCOL
ANOTHER MEDICOR WORLD FIRST - DEVELOPED BY DR. KHAN Download BrochureNow Published in European Society of Medicine Journal
Powerful Non-Toxic Cancer Treatments
Integrative treatment combining traditional and natural therapies
Leading experience worldwide with metabolic therapy using oral and intravenous DCA (dichloroacetate)
Immunotherapy with oral LDN (low dose naltrexone) based on the original research of Bernard Bihari, MD, combined with high dose vitamin D
DMSO / sodium bicarbonate infusion therapy based on the research of Dr. Ba Hoang
Nanoparticle natural immune therapy cream for skin cancers or skin metastases
Full complement of well-researched intravenous supportive infusions and natural therapies (high dose vitamin C, European mistletoe, amino acids, high dose B vitamins)
Advanced oral nanoparticle / liposomal formulations of natural medicines
Medical Ozone Therapy
Natural, safe and powerful ozone therapy
Blood ozonation (multi-pass), ozonated saline infusion, ozone insufflation, ozone tumour injection
Cancer therapy and therapy enhancement
Cancer prevention
Chemo, radiation and surgery preconditioning, enhance post-treatment healing
Supervised by American Academy of Ozone Therapy Fellow and certified Prolozone® specialist (Dr. Khan)
Many Other Ozone Benefits
True Cancer Prevention for High Risk Individuals
Reversal of Pre-Cancer (“Carcinoma In-Situ”)
Recurrence Prevention After Completion of Cancer Therapy
Reduction of Risk of Metastases with Biopsy or Surgery
Preparation for Surgery for Optimal Outcomes
Support for Standard Chemo / Radiation – Improve Results and Reduce Side Effects
Latest Publication by Dr. Khan - Mar 2024
Mar 2024 – Another world-first publication by the Medicor team calling for a major change in the way cancer is staged! Dr. Akbar Khan and his colleagues have once again demonstrated their leadership by redefining cancer care based on the latest technologies, backed by extensive scientific evidence. Published in the prestigious European Society of Medicine Journal. PDF DOWNLOAD: A Paradigm Shift in Cancer Staging- Seeing the Unseen with Circulating Tumor Cell Measurement. JOURNAL LINK: Medical Research Archives Vol 12 No 3 (2024)
For Canadian practitioners who are unable to order Circulating Tumour Cell Counts due to jurisdiction-specific rules, your patient may order with us.
Grounbreaking Metabolic Cancer Publication by Dr. Khan
July 2023 – Another world-first publication by our Medical Director Dr. Akbar Khan, together with leading American physician Dr. Mitchell Ghen. Published in the European Society of Medicine special issue of Medical Research Archives: A 15 Year Evolution of Dichloroacetate-Based Metabolic Cancer Therapy: A Review with Case Reports, Medical Research Archives, [S.l.], v. 11, n. 7.2, July 2023. ISSN 2375-1924
Colon Cancer Publication by Dr. Khan
Sep 2021 – Exciting new publication by our Medical Director Dr. Akbar Khan in the new Canadian Journal of Naturopathic Medicine! Read this revealing paper about the realities of cytotoxic chemotherapy for advanced colon cancer. Get the facts before you decide if chemo is right for you.
Critical Appraisal of Approved Chemotherapy Regimens for Advanced Colon Cancer in Ontario Canada. Khan A, Can J Naturopathic Med, Vol 1, Issue 2, Sep 2021
Dr. Khan Live on CityNews
Medicor’s Medical Director and Founder Dr. Akbar Khan appeared live on CityNews to discuss former Mayor Rob Ford’s cancer diagnosis (2014).
Exciting New Immunoptherapy Film: "The Battle Within" !
This film is the culmination of decades of investigating by Dr. Ralph Moss about a profound revolution in cancer treatment, the application of one’s own immune system towards the defeat of cancer. The Battle Within refers to the battle of the immune system against cancer…and also to the battle within the medical profession over the best method of fighting cancer. Despite the enormous amount of evidence (over 100,000 PubMed articles!) until recently, powerful financial forces have held back the field of cancer immunotherapy.
Watch the premier starting Aug 26 at 4pm EST om YouTube.
NOV 2017 METABOLIC CANCER CONFERENCE IN BALTIMORE WAS A BIG SUCCESS!
- a new concept in cancer therapy – the metabolic approach (diet, DCA, 3BP, glutamine blocking etc)
- over 40 speakers presented various topics
- many renowned doctors from USA, France, Taiwan, Canada, Greece, England and Turkey (Harvard, Johns Hopkins, U of Maryland, Columbia U, Stanford, Boston College, UCSF etc.)
- celebrity chefs and nutritionists
- Dr. Khan presented a lecture about DCA as a non-toxic metabolic cancer therapy, and moderated a panel discussion about chemotherapy
Shocking New Article by Tom Blackwell About Cancer Drugs
“…While an early stage study found the medicine shrunk tumours in about half of patients, there is no evidence…it helps them live longer or improves their quality of life. Still, manufacturer…charged a small fortune for the drug: about $122,000 a year.”
READ NOW!
New DCA Publication!
LONG TERM STABILIZATION OF METASTATIC MELANOMA WITH DCA (PDF) (HTML)
DCA therapy can result in a classic response which is measured by reduction or disappearance of tumours on imaging. However, DCA can also halt cancer cell growth without causing apoptosis (cytostatic effect). This can result in long-term stabilization of metastatic cancer. We present a case of oral DCA therapy resulting in reduction and stabilization of metastatic melanoma in a 32-year-old male for over 4 years, with only minor side effects.
Publications
BOARD OF INTEGRATIVE MEDICINE MEMBER
Medicor doctors have been featured regularly in the media since 2006
